Goldman Sachs Group Inc Monte Rosa Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 101,144 shares of GLUE stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101,144

Previous 348,208 70.95%

Holding current value

$1.45 Million

Previous $1.57 Million 52.29%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$4.19 - $7.49 $1.04 Million - $1.85 Million	-247,064 Reduced 70.95%	101,144 $749,000
Q2 2025 Aug 14, 2025	SELL	$3.7 - $5.33 $29,244 - $42,128	-7,904 Reduced 2.22%	348,208 $1.57 Million
Q1 2025 May 09, 2025	BUY	$4.64 - $7.17 $910,544 - $1.41 Million	196,238 Added 122.75%	356,112 $1.65 Million
Q4 2024 Feb 11, 2025	SELL	$4.8 - $10.36 $89,908 - $194,053	-18,731 Reduced 10.49%	159,874 $1.11 Million
Q3 2024 Nov 14, 2024	BUY	$3.59 - $6.97 $309,659 - $601,204	86,256 Added 93.4%	178,605 $946,000

Q2 2024 Aug 13, 2024	BUY	$3.38 - $7.86 $258,857 - $601,958	76,585 Added 485.82%	92,349 $345,000
Q1 2024 May 15, 2024	SELL	$4.26 - $8.46 $91,223 - $181,162	-21,414 Reduced 57.6%	15,764 $111,000
Q4 2023 Feb 13, 2024	SELL	$2.5 - $5.93 $42,580 - $100,999	-17,032 Reduced 31.42%	37,178 $210,000
Q3 2023 May 14, 2024	BUY	$4.78 - $7.22 $81,412 - $122,971	17,032 Added 45.81%	54,210 $259,000
Q3 2023 Nov 14, 2023	BUY	$4.78 - $7.22 $42,417 - $64,070	8,874 Added 19.57%	54,210 $259,000
Q2 2023 May 14, 2024	BUY	$4.53 - $8.4 $59,356 - $110,065	13,103 Added 40.65%	45,336 $310,000
Q2 2023 Aug 14, 2023	BUY	$4.53 - $8.4 $59,356 - $110,065	13,103 Added 40.65%	45,336 $310,000
Q1 2023 May 14, 2024	SELL	$5.95 - $8.21 $69,787 - $96,295	-11,729 Reduced 26.68%	32,233 $251,000
Q1 2023 May 11, 2023	SELL	$5.95 - $8.21 $69,787 - $96,295	-11,729 Reduced 26.68%	32,233 $251,000
Q4 2022 May 14, 2024	BUY	$6.71 - $9.72 $71,582 - $103,692	10,668 Added 32.04%	43,962 $334,000
Q4 2022 Feb 13, 2023	BUY	$6.71 - $9.72 $71,582 - $103,692	10,668 Added 32.04%	43,962 $334,000
Q3 2022 May 14, 2024	SELL	$7.17 - $12.16 $48,913 - $82,955	-6,822 Reduced 17.01%	33,294 $272,000
Q3 2022 Nov 10, 2022	SELL	$7.17 - $12.16 $48,913 - $82,955	-6,822 Reduced 17.01%	33,294 $272,000
Q2 2022 May 14, 2024	BUY	$6.15 - $14.99 $18,068 - $44,040	2,938 Added 7.9%	40,116 $388,000
Q2 2022 Aug 15, 2022	SELL	$6.15 - $14.99 $59,661 - $145,417	-9,701 Reduced 19.47%	40,116 $388,000
Q1 2022 May 16, 2022	BUY	$10.36 - $20.41 $156,135 - $307,599	15,071 Added 43.37%	49,817 $698,000
Q4 2021 Feb 14, 2022	BUY	$16.28 - $27.15 $254,407 - $424,273	15,627 Added 81.74%	34,746 $710,000
Q3 2021 Nov 10, 2021	BUY	$18.59 - $42.21 $355,422 - $807,012	19,119 New	19,119 $426,000

Others Institutions Holding GLUE

# of Institutions

132

Shares Held

55.7M

Call Options Held

159K

Put Options Held

269K

View Full List

About Monte Rosa Therapeutics, Inc.

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $671M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

More about GLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Monte Rosa Therapeutics, Inc. Transaction History